mHealth presents an opportunity for making healthcare more personalised, accessible and convenient. Enabling patients to avoid hospital beds in favour of monitoring conditions remotely has the potential to reduce costs, strengthen healthcare systems and improve outcomes for more people across the globe. However, with new opportunities come new challenges around data privacy and security, interoperability and how these systems will be regulated. This module addresses both the opportunities and concerns posed by advances in this sector.
Module Chair: Sabine Koll, Journalist, Konradin
The Mobile Device as a Medical Device: Latest Innovations in Technology and Security Standards
David Kleidermacher, Chief Security Officer, Blackberry
Mobile apps and software to support drug device combination products
- Outlining drug device combination products available which are supported by mobile apps
- Exploring FDA and European regulatory requirements and perspectives for apps
- Reviewing challenges with app classification in different markets as devices or not
- Clarifying the role of combination products in connected health, regulations in place and direction this is likely to develop in
- Discussing mobile app & SW combination products development and evaluation hurdles
Christophe Amiel, Partner, Voisin Consulting
The State of Healthcare Cybersecurity: Myths and Realities
• What are the key cybersecurity challenges healthcare organizations (hospitals and caregivers) are facing?
• What dynamics have changed in the past three years to bring about these challenges?
• What are the key realities and myths associated with healthcare system security?
John Gomez, CEO, Sensato
Hear from our shortlisted start-ups on the latest innovations and learn more about opportunities for partnering and collaboration.
10:30-10:35 Welcome from the Chair
10:35 - 10:50 Tarilian Laser Technologies
10:50 -11:05 Memocorby
11:05 - 11:20 Omini Pharma srls
11:20 – 11:35 xRapid
11:35 – 11:50 Novus
The Medical Device industry can no longer ignore Industry 4.0 if they wish to remain competitive in this era of digitalisation, interoperability and connectivity. How can this model be applied to your business and deliver real value and ROI?
Module Chair: Sabine Koll, Journalist, Konradin
Allianz Industrie 4.0 Baden-Württemberg - Joining forces to shape the industrial future
Katharina Mattes, Head of Coordination, Allianz Industrie 4.0 Baden-Württemberg office
10 key considerations when developing connected devices
- Key areas to prioritise in the journey from idea to commercial device
- Some of the pitfalls to avoid
- Examples from case studies
David Griffin, Senior Consultant, 42 Technology Limited
How IoT Is Transforming The Way Medical Products Are Developed?
• Changing customer needs now warrant more frequent product updates due to technological advancements, and new functional requirements
• Agility is an opportunity for developers to reduce time to market and to ensure that their products fit customer needs
• The need to maintain compliance and product safety in a fast-paced Agile environment is a challenge
Peter Haller, Senior Pre-sales Consultant, Intland Software
We revisit the 2016 Start-Up finalists to see how far they’ve come in a year – learn more about their burgeoning innovations and steps to commercialisation.
Module Chair: Jared Sebhatu, Program Director, Germany, German Accelerator Life Sciences
Where are they now? 2016 Start-Up Academy finalists roundtable
We revisit the 2016 Start-Up finalists to see how far they’ve come in a year – learn more about their burgeoning innovations and next steps to commercialisation.
Moderator: Jared Sebhatu, Program Director, Germany, German Accelerator Life Sciences
Albertus M. Scheule, CEO, CaveoMed
Paul Weinberger, CEO, Diasolve
Funding opportunities for Health and Biotech from the EU Research and Innovation program Horizon 2020
Lydia Kammler, Project Manager, DLR Project Management Agency
Connected devices have come a long way in recent years; moving beyond the novelty of wearable technologies towards connected healthcare systems that offer tangible benefits for patients. This module attempts to see beyond the hype and to address the current state of play of this sector, what are real benefits these technologies can offer patients, and what are the concerns that need to be addressed?
Module Chair: Kel Koenen, Head of Content, UBM
Connected Devices Revolution: Reality Check for Healthcare Industry
- The promise of connected devices to patients, doctors and healthcare organizations
- 5 trends transforming the consumer and professional healthcare
- Some early pioneers and promising future leaders
Bhoopathi Rapolu, Head of Analytics EMEA, Cyient
Connected Devices: A clinicians view on the tangible benefits for patients
- What are the benefits for patients in the community, attending primary care and when in hospital?
- Examples from the most exciting products coming onto the market
- What are the concerns and how can we address them?
- A realistic vision of where we might be heading
Ed Cartwright, Clinician, Scientist & Entrepreneur, Co-Founder of Cloud of Experts
eMDI - Creating Patient Value Through Increased Adherence
• Global health data confirms that poor patient adherence to long-term therapies, such as asthma and COPD, contribute significantly to rising healthcare cost.
• Smart Inhalers are emerging which enable more effective monitory of patient compliance and adherence, including remotely.
• Clinical studies using smart devices have demonstrated improvements and translate directly to a reduction in healthcare cost.
• Smart Inhalers face numerous challenges, from a wide range of stakeholder, for successful adoption on a global scale.
Dana Shears, Sales Director, H&T Presspart
The European device market may still be the strongest globally, but expanding into other regions is very much a priority for many companies. This module will examine market opportunities in the US market, while examining uncertainty on both sides of the pond, prompted by Brexit and the new US administration.
North American Market Access for Electro-Medical Devices
- Current regulatory situation: EU vs. US vs. CAN
- Necessity of product certifications and legal requirements in North America
- Differences in the product approval process in CAN and the US
Hans-Werner Zeller, Senior Business Development Manager, Health, Safety and Technology Europe, CSA Group
The Impact of Brexit on the Medical Device Industry
Fabien Roy, Counsel, Hogan Lovells
European Market Access for Medical Devices
Faraj F. Abdelnour, Director, AB Certification